Multiple candidate gene analysis identifies α-synuclein as a susceptibility gene for sporadic Parkinson's diseaseIkuko Mizuta, Tatsushi Toda, Yuko Nakabayashi et al.|Human Molecular Genetics|2006Cited by 207
Protein Aggregation Inhibitors as Disease-Modifying Therapies for Polyglutamine DiseasesEiko N. Minakawa, Yoshitaka Nagai|Frontiers in Neuroscience|2021Cited by 52
Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformationEiko N. Minakawa, Yoshitaka Nagai|Brain|2020Cited by 38
Abnormalities in synaptic dynamics during development in a mouse model of spinocerebellar ataxia type 1Yusuke Hatanaka, Yoshitaka Nagai|Scientific Reports|2015Cited by 20